# Spatiotemporal Evolution of Traditional Chinese Medicine Mechanisms in Acute Ischemic Stroke Treated With Dengzhan Xixin and Dengzhan Shengmai

Study · id `cardio:ct-nct07591883` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07591883](<https://clinicaltrials.gov/study/NCT07591883>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07591883

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 358 participants.

## Technical summary

Registry record NCT07591883. Randomized; quadruple masking; primary purpose treatment. Start 2026-06-01 (anticipated); primary completion 2029-07-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 358 participants (planned count; ClinicalTrials.gov record NCT07591883, source copy `cardio:ctgov-nct07591883-2026-05-18`, retrieved 2026-10-26)
- Planned start: 2026-06-01 (anticipated) (ClinicalTrials.gov record NCT07591883, source copy `cardio:ctgov-nct07591883-2026-05-18`, retrieved 2026-10-26)
- Primary completion: 2029-07-30 (anticipated) (ClinicalTrials.gov record NCT07591883, source copy `cardio:ctgov-nct07591883-2026-05-18`, retrieved 2026-10-26)
- Completion: 2029-07-31 (anticipated) (ClinicalTrials.gov record NCT07591883, source copy `cardio:ctgov-nct07591883-2026-05-18`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07591883-2026-05-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Spatiotemporal Evolution of Traditional Chinese Medicine Mechanisms in Acute Ischemic Stroke Treated With Dengzhan Xixin and Dengzhan Shengmai
- Acronym: STEM-DZ
- Condition: Ischemic Strokes
- Condition: Traditional Chinese Medicine (TCM)
- Condition: Prognosis
- Intervention (Drug): Dengzhan Shengmai - Erigeron breviscapus sequential intervention
- Intervention (Drug): corresponding control group sequential intervention
- Lead sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine
- Lead sponsor class: OTHER
- Collaborator: Nanfang Hospital, Southern Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine (`cardio:org-guangdong-provincial-hospital-of-traditional-chinese-befb6a`)
- Registry lists this organization as a collaborator: Nanfang Hospital, Southern Medical University (`cardio:org-nanfang-hospital-southern-medical-university`)

## Provenance

Content hash: aafb0ba5a1bbbc9845952d105183f6c2f9f3a433b66360ad74c818368b5ea8ec
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
